KAPA — Kairos Pharma Cashflow Statement
0.000.00%
Last trade - 00:00- $24.06m
- $21.03m
- 30
- 19
- 32
- 15
Annual cashflow statement for Kairos Pharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS/A | PROSPECTUS/A | PROSPECTUS/A | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -1.05 | -2.15 | -1.05 | -1.81 | -2.6 |
| Amortisation | |||||
| Non-Cash Items | 0.8 | 0.444 | 0.408 | 0.969 | 0.472 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.213 | 1.19 | 0.129 | 0.764 | -1.98 |
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -0.039 | -0.412 | -0.353 | 0.081 | -3.96 |
| Other Investing Cash Flow Items | 0 | -0.109 | — | — | — |
| Acquisition of Business | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0 | -0.109 | — | — | — |
| Financing Cash Flow Items | -0.013 | 0 | -0.178 | -0.425 | -0.39 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.037 | 0.58 | 0.717 | -0.425 | 5.13 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.002 | 0.059 | 0.364 | -0.344 | 1.18 |